AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
05 January 2023 - 08:05AM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the 41st Annual J.P. Morgan Healthcare
Conference on Wednesday, January 11, 2023, at 2:15 p.m. Pacific
Time (5:15 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce costs, and tackle the toughest problems in
drug development. For more information, please visit
www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230103005877/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Feb 2024 to Mar 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2023 to Mar 2024